<code id='9981275DFD'></code><style id='9981275DFD'></style>
    • <acronym id='9981275DFD'></acronym>
      <center id='9981275DFD'><center id='9981275DFD'><tfoot id='9981275DFD'></tfoot></center><abbr id='9981275DFD'><dir id='9981275DFD'><tfoot id='9981275DFD'></tfoot><noframes id='9981275DFD'>

    • <optgroup id='9981275DFD'><strike id='9981275DFD'><sup id='9981275DFD'></sup></strike><code id='9981275DFD'></code></optgroup>
        1. <b id='9981275DFD'><label id='9981275DFD'><select id='9981275DFD'><dt id='9981275DFD'><span id='9981275DFD'></span></dt></select></label></b><u id='9981275DFD'></u>
          <i id='9981275DFD'><strike id='9981275DFD'><tt id='9981275DFD'><pre id='9981275DFD'></pre></tt></strike></i>

          Home / explore / entertainment

          entertainment


          entertainment

          author:focus    Page View:92891
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In